Networking - Latest Developments in CRISPR Technology for Functional Genomics in Oncology

Presentation

Fri 7 December

[Schedule with Tracks only]

DAY 1

Horobin Room

DAY 1

DAY 1	Horobin Room	DAY 1
2:00		2:00:
2:05:		2:05:
2:10:		2:10:
2:15:		2:15:
2:20:		2:20:
2:25:		2:25:
2:30:	Registration	2:30:
2:35:		2:35:
2:40:		2:40:
2:45:		2:45:
2:50:		2:50:
2:55:		2:55:
3:00	Latest Developments in CRISPR Technology for Functional Genomics in Oncology Functional Genomics at AstraZeneca 15:00 (20 mins) Steve Rees, AstraZeneca	3:00:
3:05:		3:05:
3:10:		3:10:
3:15:		3:15:
3:20:	Latest Developments in CRISPR Technology for Functional Genomics in Oncology Strategic vision of functional genomic 15:20 (20 mins) Greg Hannon, CRUK	3:20:
3:25:		3:25:
3:30:		3:30:
3:35:		3:35:
3:40:	Latest Developments in CRISPR Technology for Functional Genomics in Oncology RNA processing as a genetic vulnerability of AML 15:40 (40 mins) George Vassiliou, Wellcome Sanger Institute	3:40:
3:45:		3:45:
3:50:		3:50:
3:55:		3:55:
4:00		4:00:
4:05:		4:05:
4:10:		4:10:
4:15:		4:15:
4:20:	Latest Developments in CRISPR Technology for Functional Genomics in Oncology Retooling CRISPR to turn genes on and off 16:20 (30 mins) Luke Gilbert, UCSF Hellen Diller Comprehensive Cancer Center	4:20:
4:25:		4:25:
4:30:		4:30:
4:35:		4:35:
4:40:		4:40:
4:45:		4:45:
4:50:	Latest Developments in CRISPR Technology for Functional Genomics in Oncology Shining a light on drug resistance landscapes using genome-wide CRISPR screens 16:50 (30 mins)	4:50:
4:55:		4:55:
5:00		5:00:
5:05:		5:05:
5:10:		5:10:
5:15:		5:15:
5:20:	Networking with refreshments	5:20:
5:25:		5:25:
5:30:		5:30:
5:35:		5:35:
5:40:		5:40:
5:45:		5:45:
5:50:		5:50:
5:55:		5:55:
6:00		6:00:
6:05:		6:05:
6:10:		6:10:
6:15:		6:15:
6:20:		6:20:
6:25:		6:25:
6:30:		6:30:
6:35:		6:35:
6:40:		6:40:
6:45:		6:45:
6:50:		6:50:
6:55:		6:55:
7:00		7:00: